Literature DB >> 20064818

Relationship of interleukin-6 with regional and global left-ventricular function in asymptomatic individuals without clinical cardiovascular disease: insights from the Multi-Ethnic Study of Atherosclerosis.

Andrew T Yan1, Raymond T Yan, Mary Cushman, Alban Redheuil, Russell P Tracy, Donna K Arnett, Boaz D Rosen, Robyn L McClelland, David A Bluemke, Joao A C Lima.   

Abstract

AIMS: We sought to examine the relationship between circulating interleukin-6 (IL-6) level and regional left-ventricular (LV) function among apparently healthy individuals free of cardiovascular disease. METHODS AND
RESULTS: Using magnetic resonance myocardial tagging, we determined peak systolic circumferential strain (Ecc) as a measure of regional systolic function in 894 asymptomatic participants in the Multi-Ethnic Study of Atherosclerosis. Ecc was analysed by harmonic phase imaging separately in the LV anterior wall, septum, lateral wall, and inferior wall. Global Ecc was calculated as the average of Ecc in all myocardial segments. We performed multivariable linear regression to evaluate the independent associations between log IL-6 and Ecc, after adjusting for demographic features, cardiovascular risk factors, and markers of subclinical atherosclerosis. The inverse relationships between IL-6 and absolute Ecc were similar in both genders. In multivariable analysis, higher IL-6 level was independently associated with reduced systolic function (less negative Ecc) in the septum [regression coefficient = 1.03 per unit higher log IL-6, 95% confidence interval (CI) 0.26-1.79, P = 0.008] and inferior wall (regression coefficient = 1.65, 95% CI 0.74-2.56, P < 0.001), but not in the anterior wall (P = 0.27) or lateral wall (P = 0.52). Overall, there was an independent inverse association between IL-6 and global Ecc (regression coefficient = 0.94, 95% CI 0.37-1.51, P = 0.001). Compared with C-reactive protein, higher IL-6 level demonstrates a stronger independent association with reduced regional systolic function.
CONCLUSION: In asymptomatic men and women without documented cardiovascular disease, there is a strong, independent, inverse relationship between IL-6 and regional LV systolic function. These findings suggest that IL-6 may underlie the pathogenetic link between inflammation, LV dysfunction and incipient heart failure. The observed variable relationships between IL-6 and systolic function across different LV regions warrant further investigations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20064818      PMCID: PMC2848322          DOI: 10.1093/eurheartj/ehp454

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  42 in total

1.  Fast determination of regional myocardial strain fields from tagged cardiac images using harmonic phase MRI.

Authors:  J Garot; D A Bluemke; N F Osman; C E Rochitte; E R McVeigh; E A Zerhouni; J L Prince; J A Lima
Journal:  Circulation       Date:  2000-03-07       Impact factor: 29.690

2.  Interleukin-6: a neurohumoral predictor of prognosis in patients with heart failure: light and shadow.

Authors:  R Ferrari
Journal:  Eur Heart J       Date:  2002-01       Impact factor: 29.983

3.  Do cytokines enable risk stratification to be improved in NYHA functional class III patients? Comparison with other potential predictors of prognosis.

Authors:  R Kell; A Haunstetter; T J Dengler; C Zugck; W Kübler; M Haass
Journal:  Eur Heart J       Date:  2002-01       Impact factor: 29.983

4.  Elevated homocysteine is associated with reduced regional left ventricular function: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Khurram Nasir; Michael Tsai; Boaz D Rosen; Veronica Fernandes; David A Bluemke; Aaron R Folsom; João A C Lima
Journal:  Circulation       Date:  2007-01-02       Impact factor: 29.690

5.  Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction.

Authors:  R J Raymond; G J Dehmer; T C Theoharides; E N Deliargyris
Journal:  Am Heart J       Date:  2001-03       Impact factor: 4.749

6.  Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study.

Authors:  J S Gottdiener; A M Arnold; G P Aurigemma; J F Polak; R P Tracy; D W Kitzman; J M Gardin; J E Rutledge; R C Boineau
Journal:  J Am Coll Cardiol       Date:  2000-05       Impact factor: 24.094

7.  High levels of plasma brain natriuretic peptide and interleukin-6 after optimized treatment for heart failure are independent risk factors for morbidity and mortality in patients with congestive heart failure.

Authors:  K Maeda; T Tsutamoto; A Wada; N Mabuchi; M Hayashi; T Tsutsui; M Ohnishi; M Sawaki; M Fujii; T Matsumoto; M Kinoshita
Journal:  J Am Coll Cardiol       Date:  2000-11-01       Impact factor: 24.094

8.  Elevated tumor necrosis factor-alpha and interleukin-6 in myocardium and serum of malfunctioning donor hearts.

Authors:  E J Birks; P B Burton; V Owen; A J Mullen; D Hunt; N R Banner; P J Barton; M H Yacoub
Journal:  Circulation       Date:  2000-11-07       Impact factor: 29.690

9.  Leukemia Inhibitory Factor and Interleukin-6 downregulate sarcoplasmic reticulum Ca2+ ATPase (SERCA2) in cardiac myocytes.

Authors:  S Villegas; F J Villarreal; W H Dillmann
Journal:  Basic Res Cardiol       Date:  2000-02       Impact factor: 17.165

10.  Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.

Authors:  P M Ridker; N Rifai; M J Stampfer; C H Hennekens
Journal:  Circulation       Date:  2000-04-18       Impact factor: 29.690

View more
  25 in total

Review 1.  Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation.

Authors:  Weiwei Li; Brian Olshansky
Journal:  Heart Fail Rev       Date:  2011-03       Impact factor: 4.214

2.  Cross-sectional relationship of a Mediterranean type diet to diastolic heart function in chronic heart failure patients.

Authors:  Christina Chrysohoou; Christos Pitsavos; George Metallinos; Christos Antoniou; Evaggelos Oikonomou; Iason Kotroyiannis; Apostolis Tsantilas; George Tsitsinakis; Dimitris Tousoulis; Demosthenes B Panagiotakos; Christodoulos Stefanadis
Journal:  Heart Vessels       Date:  2011-09-27       Impact factor: 2.037

3.  Cardiac and inflammatory biomarkers in perinatally HIV-infected and HIV-exposed uninfected children.

Authors:  James D Wilkinson; Paige L Williams; Wendy Yu; Steven D Colan; Armando Mendez; Justin P V Zachariah; Russell B Van Dyke; William T Shearer; Renee E Margossian; Steven E Lipshultz
Journal:  AIDS       Date:  2018-06-19       Impact factor: 4.177

Review 4.  Reappraisal of Inflammatory Biomarkers in Heart Failure.

Authors:  Thanat Chaikijurajai; W H Wilson Tang
Journal:  Curr Heart Fail Rep       Date:  2020-02

5.  The prognostic value of high sensitivity C-reactive protein in a multi-ethnic population after >10 years of follow-up: The Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Miguel Cainzos-Achirica; Michael D Miedema; John W McEvoy; Mary Cushman; Zeina Dardari; Philip Greenland; Khurram Nasir; Matthew J Budoff; Mouaz H Al-Mallah; Joseph Yeboah; Roger S Blumenthal; Josep Comin-Colet; Michael J Blaha
Journal:  Int J Cardiol       Date:  2018-08-01       Impact factor: 4.164

6.  Interleukin-6 is independently associated with right ventricular function in pulmonary arterial hypertension.

Authors:  Kurt W Prins; Stephen L Archer; Marc Pritzker; Lauren Rose; E Kenneth Weir; Alok Sharma; Thenappan Thenappan
Journal:  J Heart Lung Transplant       Date:  2017-09-01       Impact factor: 10.247

Review 7.  Interleukin-6 signaling, soluble glycoprotein 130, and inflammation in heart failure.

Authors:  Erik Tandberg Askevold; Lars Gullestad; Christen P Dahl; Arne Yndestad; Thor Ueland; Pål Aukrust
Journal:  Curr Heart Fail Rep       Date:  2014-06

8.  Prognostic value of myocardial circumferential strain for incident heart failure and cardiovascular events in asymptomatic individuals: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Eui-Young Choi; Boaz D Rosen; Veronica R S Fernandes; Raymond T Yan; Kihei Yoneyama; Sirisha Donekal; Anders Opdahl; Andre L C Almeida; Colin O Wu; Antoinette S Gomes; David A Bluemke; Joao A C Lima
Journal:  Eur Heart J       Date:  2013-05-03       Impact factor: 29.983

9.  Deletion of interleukin-6 prevents cardiac inflammation, fibrosis and dysfunction without affecting blood pressure in angiotensin II-high salt-induced hypertension.

Authors:  Germán E González; Nour-Eddine Rhaleb; Martin A D'Ambrosio; Pablo Nakagawa; Yunhe Liu; Pablo Leung; Xiangguo Dai; Xiao-Ping Yang; Edward L Peterson; Oscar A Carretero
Journal:  J Hypertens       Date:  2015-01       Impact factor: 4.844

10.  Potential cardiovascular disease risk markers among HIV-infected women initiating antiretroviral treatment.

Authors:  Robert C Kaplan; Alan L Landay; Howard N Hodis; Stephen J Gange; Philip J Norris; Mary Young; Kathryn Anastos; Phyllis C Tien; Xiaonan Xue; Jason Lazar; Christina M Parrinello; Lorie Benning; Russell P Tracy
Journal:  J Acquir Immune Defic Syndr       Date:  2012-08-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.